The Scottish Parliament passed legislation in 2012, known as the Alcohol (Minimum Pricing) (Scotland) Act 2012, which allowed the introduction of a system of Minimum Unit Pricing for alcohol.
Minimum unit pricing sets a ‘floor price’ for a unit of alcohol, now 50p per unit as of 1st May 2018, meaning it can’t be sold for lower than that. The aim of the MUP legislation, according to the Scottish Government, is to reduce the effects of harmful alcohol consumption, and improve the health and wellbeing of Scotland’s population.
We are conducting a study, funded by the NIHR and led by the University of Glasgow, to measure the effect of minimum unit pricing in emergency care settings.
For further information on minimum unit pricing,
For further information on this study please refer to the University of Glasgow website
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.